Immunoprophylaxis of viral hepatitis;Impfprophylaxe bei viralen hepatitiden

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 7, 1997, Pages 585-590

  Jilg, W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Active immunization; Hepatitis A; Hepatitis B; Passive immunization; Vaccines

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS ANTIBODY; HEPATITIS B VACCINE; HEPATITIS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY PRODUCTION; DEVELOPING COUNTRY; ENDEMIC DISEASE; GERMANY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; INDUSTRIALIZATION; PASSIVE IMMUNIZATION; REVIEW; VIRUS CARRIER; VIRUS HEPATITIS;

ADULT; CHILD; GERMANY; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS C; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, PASSIVE; RISK FACTORS; VIRAL HEPATITIS VACCINES;

EID: 0030761861     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. André FE, Hepburn A, D'Hondt E. Inactivated vaccines for hepatitis A. In: Melnick JL (Hrsg.). Prog Med Virol, Vol 37, Basel. Karger.1990; 72-95
2. Ellerbeck E, Lewis J. Midthun K et al. Safety and immunogenicity of an inactivated hepatitis A virus vaccine. In: Hollinger FB. Lemon SM. Margolis H (Hrsg.): Viral hepatitis and liver disease. Baltimore. Williams & Wilkins, 1990: 91-3
3. André FE. Epidemiology and prevention of hepatitis A. In: Arroyo V, Bosch J, Rodés J (eds.). Treatments in hepatology. Masson SA, Barcelona 1995: pp 215-8
4. Impfempfehlungen der ständigen Impfkommission am Robert-Koch-Institut (Oktober 1995). Bundesgesundhbl 1996; 39: 32-41
5. Müller R, Gurbernatis G, Farle M et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 90
6. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles from recombinant yeast. Nature 1982; 298: 347-50
7. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report. Hepatology 1981; 1: 377-85
8. Carman WF, Zanetti A, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 11: 325-9
9. Centers for Disease Control. Hepatitis B: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the immunization practices advisory committee (ACIP). Morbid. Mortal. Weekly Record 1991; 40: 1-25
10. Jilg W, Schmidt M, Deinhardt F. Immune response to hepatitis B revaccination. J Med Virol 1988; 24: 377-84
11. Schweizer Expertengruppe für virale Hepatitis (SEVHEP), Hepatitis-B-Impfung: Ist eine Auffrischimpfung noch nötig? Bulletin des Bundesamtes für Gesundheitswesen 1995; 20: 12-6
12. Public health. Immunisation against hepatitis B. Lancet 1988; i: 875-6
13. Chriske HW, Hermann C. Die Bedeutung des immunologischen Gedächtnisses für die Hepatitis-B-Auffrischimpfung. Vortrag, 34. Jahrestagung in Wiesbaden der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V. 1994
14. Dennhöfer L. Hepatitis-B-Schutzimpfung. Zum Problem der ungenügenden Anti-HBs-Bildung. Dsch Med Wochenschr 1990; 115: 1560-5
15. Meuer S, Dumann H, Meyer zum Büschenfelde KH, Köhler II. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient nonresponders to hepatitis B vaccination. Lancet 1989: I: 15-8
16. Jilg W, Schmidt M. Deinhardt F. Impfversager nach Hepatitis-B-Impfung: Effekt zusätzlicher Impfungen. Dtsch Med Wschr 1990; 115: 1545-8
17. Houghton M, Choo QL. Kuo G et al. HCV vaccine: Interim report. IX Triennial international symposium on viral hepatitis and liver disease. Rome. April 21-25, 1996. Abstract No. 150
18. Purdy MA, McCaustland KA, Krawcynski K et al. Prelimimnary evidence that a trp-HEV fusion protein protects cynomolgus macaques against challenge with wildtype hepatitis E virus (HEV). J Med Virol 1993: 41: 90-4